unknown
Stage
1
Investors
About
Immunovant, Inc. is a clinical-stage biopharmaceutical company developing therapeutic candidates to treat autoimmune diseases with the goal of enabling normal lives for patients.
Explore Immunovant's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.